Angiotensin-converting enzyme assay optimization: Influence of various buffers and their concentrations

Clinical Biochemistry

Volumn 33, Issue 8, 2000, Pages 687-689

  Bala, Manju ^a   Gupta, Suparna ^b   Pasha, M A Q ^a,b  

^a UNIVERSITY OF DELHI   (India)

^b CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BUFFER; DIPEPTIDYL CARBOXYPEPTIDASE;

ARTICLE; BLOOD PRESSURE REGULATION; BLOOD SAMPLING; CONCENTRATION RESPONSE; DIAGNOSTIC VALUE; ENZYME ACTIVITY; ENZYME ASSAY; HUMAN; HYPERTENSION; PRIORITY JOURNAL; PROGNOSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SARCOIDOSIS;

EID: 0034483710     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(00)00180-6     Document Type: Article

References (9)

1. Cardiac angiotensin-converting enzyme activity in myocardial infarction
2. Non-adherence and ACE inhibitor treatment is common in heart failure and can be detected by routine serum ACE activity assays
3. A continuous assay for angiotensin-converting enzyme
4. Direct spectrophotometric assay for angiotensin-converting enzyme in serum
5. Automated kinetic assay of angiotensin-converting enzyme in serum
6. Assessment and optimization of kinetic methods for angiotensin-converting enzyme in plasma
7. An insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene accounting for half the variance of serum enzyme levels
8. The two homologous domains of human angiotensin I-converting enzyme interact differently with competitive inhibitors
9. Activation of angiotensin-converting enzyme by monovalent anions